MDL® Isentris®Integration and analysis of scientific information
Abstract
This white paper explains the business need and technical delivery of Elsevier MDL’s flagship MDL® Isentris® system. As the new generation of MDL technology, Isentris addresses the twin challenges facing pharmaceutical companies today:
- The need to adopt a standard business intelligence platform to support research and development
- The requirement to become a knowledge-led organization
Based on open standards, MDL Isentris offers application developers a suite of reusable programming components that can be incorporated within new or existing applications using standard development technologies. MDL Isentris integrates with service-oriented architectures (SOA) and offers a broad portfolio of discovery-specific services that can be immediately deployed to further enhance productivity.
With Isentris, R&D organizations can capitalize on their previous investments in MDL® ISIS and other MDL® technologies, while also gaining the many advantages of a new-generation, data-integrating infrastructure.
This paper is available upon request. To request your copy, complete the contact form and indicate the name of the paper in the question/comment box.
